MG
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
VivoPower PLC
VIVO
$70.1M
| $91.4K | ﹤0.01% |
39,754
| – | – |
2025 Q3
2 quarters
|
|
952
Savers
SVV
$1.43B
| $89.3K | ﹤0.01% |
12,000
-3,000
| -20% | -$28.7K |
2025 Q4
1 quarter
|
|
953
AudioEye
AEYE
$85.2M
| $89.1K | ﹤0.01% |
+13,984
| New | +$106K |
2026 Q1
0 quarters
|
|
954
CALL
Prairie Operating Co
PROP
$41.5M
| $81.2K | ﹤0.01% |
+40,000
| New | +$72.3K |
2026 Q1
0 quarters
|
|
955
Sharplink Inc
SBET
$1.72B
| $80K | ﹤0.01% |
12,396
-41,305
| -77% | -$334K |
2025 Q3
2 quarters
|
|
956
SkinHealth Systems
SKIN
$75.2M
| $77.2K | ﹤0.01% |
4,335
| – | – |
2025 Q4
1 quarter
|
|
957
Black Titan Corp
BTTC
$5.7M
| $77K | ﹤0.01% |
54,983
+4,511
| +9% | +$7.48K |
2025 Q4
1 quarter
|
|
958
Lucas GC Ltd
LGCL
$2.42M
| $71K | ﹤0.01% |
+371
| New | +$86.9K |
2026 Q1
0 quarters
|
|
959
A2Z Smart Technologies
AZ
$245M
| $66.7K | ﹤0.01% |
10,000
-18,000
| -64% | -$115K |
2025 Q3
2 quarters
|
|
960
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$21.5M
| $65K | ﹤0.01% |
13,468
+32
| +0.2% | +$144 |
2025 Q3
2 quarters
|
|
961
Infleqtion Inc Warrants
INFQ.WS
| $62.9K | ﹤0.01% |
+14,220
| New | +$75.7K |
2026 Q1
0 quarters
|
|
962
Hertz
HTZ
$659M
| $62.2K | ﹤0.01% |
13,493
+399
| +3% | +$1.93K |
2025 Q4
1 quarter
|
|
963
Kosmos Energy
KOS
$1.61B
| $61.9K | ﹤0.01% |
22,261
-240
| -1% | -$451 |
2025 Q3
2 quarters
|
|
964
Phoenix New Media
FENG
$17.3M
| $61.3K | ﹤0.01% |
35,000
| – | – |
2025 Q3
2 quarters
|
|
965
Virgin Galactic
SPCE
$387M
| $60.9K | ﹤0.01% |
+25,075
| New | +$68K |
2026 Q1
0 quarters
|
|
966
Vertical Aerospace
EVTL
$61M
| $59.9K | ﹤0.01% |
+27,091
| New | +$123K |
2026 Q1
0 quarters
|
|
967
Rapid7
RPD
$834M
| $58.9K | ﹤0.01% |
10,683
-1
| -0% | -$9 |
2025 Q4
1 quarter
|
|
|
VBIO
968
Valion Bio
VBIO
$1.29M
| $52.5K | ﹤0.01% |
2,371
+733
| +45% | +$18.8K |
2025 Q2
3 quarters
|
|
969
Medical Properties Trust
MPT
$1.83B
| $49.7K | ﹤0.01% |
10,741
-11,597
| -52% | -$60.5K |
2025 Q4
1 quarter
|
|
970
Richtech Robotics
RR
$320M
| $47.5K | ﹤0.01% |
+22,744
| New | +$69.9K |
2026 Q1
0 quarters
|
|
971
SELLAS Life Sciences
SLS
$2.4B
| $45.8K | ﹤0.01% |
+10,833
| New | +$48.5K |
2026 Q1
0 quarters
|
|
972
Canopy Growth
CGC
$302M
| $44K | ﹤0.01% |
+46,373
| New | +$51.1K |
2026 Q1
0 quarters
|
|
|
973
PUT
Canopy Growth
CGC
$302M
| $42.1K | ﹤0.01% |
+44,400
| New | +$48.9K |
2026 Q1
0 quarters
|
|
974
FerroAtlántica
GSM
$725M
| $41.2K | ﹤0.01% |
+10,001
| New | +$48.2K |
2026 Q1
0 quarters
|
|
975
Golden Heaven Group Holdings
GDHG
$64.8M
| $40.9K | ﹤0.01% |
+23,484
| New | +$45.9K |
2026 Q1
0 quarters
|
|
Similar funds
AF
NAM
ATO
DSA
A
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.